When you private label skincare, formula ownership is set by the manufacturing contract, not by who pays for it or whose name is on the bottle. If you want private label formula ownership to sit with your brand, it has to be written into the agreement before development starts—otherwise you may be licensing a formula the manufacturer can reuse for other brands.

What does "formula ownership" actually mean?

The formula is the recipe: the ingredient list, the concentrations, the process know-how and the master batch record. It is separate from three other things brands often confuse it with. The trademark is your brand name and logo. The regulatory filing—the Responsible Person in some markets, or the local 备案 holder—is who places the product on the market. And the finished goods are what you sell. Owning one of these does not automatically grant the others, so it is cleaner to keep them apart when you negotiate.

Who usually owns the formula in each private label model?

The answer shifts with the manufacturing model you choose:

ModelWho usually holds the formulaWhat the brand typically gets
Stock / white-label baseManufacturerThe right to sell a filled product under its own label; little or no formula ownership
Custom OEMBrand, if IP is assigned in the contractControl of the specification; actual ownership depends on the assignment clause
ODMManufacturerA license to use the formula for its SKUs, either exclusively or non-exclusively

The pattern is consistent: ownership follows the contract, not the conversation. A manufacturer that develops a custom formula for you does not hand over ownership by default.

Why this matters shows up when two brands sell the same base under different labels. With a non-exclusive white-label or ODM formula, a competitor can launch a near-identical product, and you have little contractual ground to stop it. Exclusivity is the clause that prevents this, which is why brands weighing private label formula ownership usually care about it as much as the unit price.

Cosmetic specification sheet beside glass beakers with emulsion and technician hands in gloves in a softly lit laboratory

What should the contract actually say?

This is a business and contracting matter, not something fixed by cosmetics law, so the practical move is to discuss it with your manufacturer and legal counsel. The points worth pinning down in writing:

  • Confidentiality (NDA). Sign it before you share the brief, so the formula concept and your inputs are protected during discussions.
  • Assignment vs. license. Is the formula assigned to your brand (you own it), or licensed (you may use it while the manufacturer keeps ownership)?
  • Exclusive vs. non-exclusive. Exclusive means the manufacturer cannot sell the same formula to other brands; non-exclusive means it can. This choice affects price, MOQ and competitive risk.
  • Reuse restrictions. Can the manufacturer resell your formula or the improvements you funded to third parties? Can it reuse your improvements in other clients’ products?
  • Documentation. Who holds the master specification, the Certificate of Analysis (COA) and batch records, and does your brand receive a copy?
  • Portability. If you switch manufacturers later, what documents and rights transfer so you can move production without starting over?

A practical point brands miss: a license ends where the contract ends. If the agreement only licenses the formula to you, ending the partnership can mean losing the right to keep selling that product unless the contract states otherwise. An assignment, by contrast, transfers the rights to your brand for as long as you hold them. The words "license" and "assign" change what you can do after the relationship ends, so they are worth reading carefully rather than assuming.

How do you protect your position in practice?

A short checklist covers most of the risk:

  1. Sign an NDA before any brief or formula input leaves your hands.
  2. State ownership explicitly—assignment to the brand, or a license with clear scope.
  3. Choose exclusive or non-exclusive on purpose, not by default.
  4. Keep your own copy of the specification and key records.
  5. Limit the manufacturer’s right to reuse your formula or your funded improvements for other brands.
  6. Register your trademark yourself; it is independent of the formula.
Unbranded private label skincare bottle beside a confidential agreement folder on a neutral studio surface

None of these steps requires you to be a chemist. They require the arrangement to be stated clearly before samples are made.

What changes the answer by market?

Formula ownership itself is a contract question and stays largely the same across markets. What changes is the claim side: which claims you may make, and how they must be substantiated, varies by market and product type. Keep claim rules separate from IP ownership, and confirm the applicable requirements for each target market before finalizing artwork. A claim that is acceptable in one region may need different wording or substantiation elsewhere.

Common misconception: paying means owning

Paying for development does not, by itself, transfer formula ownership. Many brands assume that because they funded a custom formula, it is theirs. Unless the agreement assigns the IP in writing, the manufacturer may retain it and license use back to you—sometimes non-exclusively, so the same formula can appear under competing labels. Read the clause; do not assume it. The cost you pay is for development and production, not automatically for the rights.

If you are scoping a private label line and want to pressure-test your formulation brief and ownership terms against real production constraints, our technical team can review the arrangement with you before sampling begins.

Related reading